154 related articles for article (PubMed ID: 31275861)
1. Fra-1 and c-Fos N-Terminal Deletion Mutants Impair Breast Tumor Cell Proliferation by Blocking Lipid Synthesis Activation.
Racca AC; Prucca CG; Caputto BL
Front Oncol; 2019; 9():544. PubMed ID: 31275861
[TBL] [Abstract][Full Text] [Related]
2. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
Motrich RD; Castro GM; Caputto BL
PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
[TBL] [Abstract][Full Text] [Related]
3. c-Fos activates and physically interacts with specific enzymes of the pathway of synthesis of polyphosphoinositides.
Alfonso Pecchio AR; Cardozo Gizzi AM; Renner ML; Molina-Calavita M; Caputto BL
Mol Biol Cell; 2011 Dec; 22(24):4716-25. PubMed ID: 21998197
[TBL] [Abstract][Full Text] [Related]
4. c-Fos-activated synthesis of nuclear phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P₂] promotes global transcriptional changes.
Ferrero GO; Renner ML; Gil GA; Rodríguez-Berdini L; Caputto BL
Biochem J; 2014 Aug; 461(3):521-30. PubMed ID: 24819416
[TBL] [Abstract][Full Text] [Related]
5. Impairing activation of phospholipid synthesis by c-Fos interferes with glioblastoma cell proliferation.
Prucca CG; Racca AC; Velazquez FN; Cardozo Gizzi AM; Rodríguez Berdini L; Caputto BL
Biochem J; 2020 Dec; 477(23):4675-4688. PubMed ID: 33211090
[TBL] [Abstract][Full Text] [Related]
6. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
7. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
8. Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility.
Tkach V; Tulchinsky E; Lukanidin E; Vinson C; Bock E; Berezin V
Oncogene; 2003 Aug; 22(32):5045-54. PubMed ID: 12902987
[TBL] [Abstract][Full Text] [Related]
9. The ability of Fos family members to produce phenotypic changes in epithelioid cells is not directly linked to their transactivation potentials.
Andersen H; Mahmood S; Tkach V; Cohn M; Kustikova O; Grigorian M; Berezin V; Bock E; Lukanidin E; Tulchinsky E
Oncogene; 2002 Jul; 21(31):4843-8. PubMed ID: 12101423
[TBL] [Abstract][Full Text] [Related]
10. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of transcription factor Fra-1 in ER-positive breast cancer: contribution to a metastatic phenotype through modulation of tumor cell adhesive properties.
Oliveira-Ferrer L; Kürschner M; Labitzky V; Wicklein D; Müller V; Lüers G; Schumacher U; Milde-Langosch K; Schröder C
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1715-26. PubMed ID: 25666264
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal c-Fos tyrosine phosphorylation regulates c-Fos/ER association and c-Fos-dependent phospholipid synthesis activation.
Portal MM; Ferrero GO; Caputto BL
Oncogene; 2007 May; 26(24):3551-8. PubMed ID: 17160021
[TBL] [Abstract][Full Text] [Related]
13. c-Fos: an AP-1 transcription factor with an additional cytoplasmic, non-genomic lipid synthesis activation capacity.
Caputto BL; Cardozo Gizzi AM; Gil GA
Biochim Biophys Acta; 2014 Sep; 1841(9):1241-6. PubMed ID: 24886961
[TBL] [Abstract][Full Text] [Related]
14. Lipid Metabolism in Neurons: A Brief Story of a Novel c-Fos-Dependent Mechanism for the Regulation of Their Synthesis.
Rodríguez-Berdini L; Caputto BL
Front Cell Neurosci; 2019; 13():198. PubMed ID: 31133814
[TBL] [Abstract][Full Text] [Related]
15. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.
Prusty BK; Das BC
Int J Cancer; 2005 Mar; 113(6):951-60. PubMed ID: 15514944
[TBL] [Abstract][Full Text] [Related]
17. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
18. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
19. Controlling cytoplasmic c-Fos controls tumor growth in the peripheral and central nervous system.
Gil GA; Silvestre DC; Tomasini N; Bussolino DF; Caputto BL
Neurochem Res; 2012 Jun; 37(6):1364-71. PubMed ID: 22476983
[TBL] [Abstract][Full Text] [Related]
20. c-Fos activated phospholipid synthesis is required for neurite elongation in differentiating PC12 cells.
Gil GA; Bussolino DF; Portal MM; Alfonso Pecchio A; Renner ML; Borioli GA; Guido ME; Caputto BL
Mol Biol Cell; 2004 Apr; 15(4):1881-94. PubMed ID: 14767061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
